Whalesbook
Chemkart India ka FY26 Ka Financial Update
Chemkart India ne FY26 ke liye apne results disclose kiye hain, jisme consolidated revenue 5.7% badhkar ₹214.83 Crore (yaani ₹21,482.91 lakh) pahunch gaya hai. Pichhle saal ke comparison mein revenue mein yeh growth volumes mein kareeb 7.1% ki tezi ke karan hui hai.
Is fiscal year mein company ka Profit After Tax (PAT) ₹19.66 Crore (ya ₹1,965.5 lakh) raha, jo ki 9.1% ki PAT margin dikhata hai. Consolidated EBITDA ₹28.18 Crore (ya ₹2,817.7 lakh) bana hai, jisme 13.1% ki EBITDA margin hai. Aur haan, 31 March 2026 tak company ke paas advance aur open orders ₹65.26 Crore (ya ₹6,526 lakh) se zyada ke hain.
CDMO Segment Mein Entry Aur Manufacturing Power-up
Chemkart India ki ek badi strategy hai CDMO (Contract Development and Manufacturing Organization) segment mein expansion karna. Isse company apne higher-margin services ko diversify karna chahti hai, jiske liye R&D aur product innovation pe focus kiya ja raha hai.
Saath hi, company apne EZRM Special Economic Zone (SEZ) manufacturing facility pe bhi steady progress kar rahi hai. Is facility ko operationalize karne se unki manufacturing capabilities badhegi aur export competitiveness mein bhi zabardast sudhar aayega. Yeh 'Make in India' aur PLI schemes jaisi national initiatives ke saath bhi align karta hai.
Aage Kya? Risks Kya Hain?
Yeh sab strategic moves Chemkart ki value-added product portfolio ko strong karne aur revenue streams ko diversify karne mein madad karenge. Lekin company yeh bhi jaanti hai ki future performance market ke risks aur uncertainties par depend karti hai, jaise macroeconomic factors, competition aur badalti market preferences. Strategi ka successful execution hi growth ki chabi hoga.